A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND β-GLUCAN PGG IN RELAPSED/REFRACTORY INDOLENT B-CELL NON-HODGKIN LYMPHOMA

Authors :: Eric D. Jacobsen
Carol Reynolds
David C. Fisher
P. Armand
N. Ottoson
Marie Fields
Caron A. Jacobson
Ann S. LaCasce
Robert A. Redd
Arnold S. Freedman
N. Bose
Source :: Hematological Oncology. 37:521-523
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: chemistry.chemical_classification
Cancer Research
business.industry
Phases of clinical research
Hematology
General Medicine
Oncology
chemistry
Relapsed refractory
medicine
Cancer research
B-Cell Non-Hodgkin Lymphoma
Rituximab
business
medicine.drug
Glucan

Full Text Access

Tools